Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 103 for “"KRAS mutations"”.
-
Central sensitization and somatic activating KRAS mutations in endometriosis-associated pain
… and peripheral factors (e.g., somatic mutations in endometriosis lesions). Central nervous system amplification of pain pathways (central sensitization) has been found in people with endometriosis and pelvic pain, which manifests as non-gynecologic pain contributors (central sensitivity …
-
Investigating the cooperation of APC and KRAS mutations in colorectal cancer
… progresses in a stepwise manner accumulating mutations in particular signalling pathways. Despite our knowledge of the genetic progression of the disease, the resulting phenotypes of the different mutation combinations remains poorly understood. I used genetically engineered mouse models to …
-
KRAS mutations of the lung adenocarcinoma genome and their impact on inflammation
… um zu entdecken, dass Karzinomzellen, die KRAS-Mutationen beherbergen, MPE produzieren, während Zellen ohne solche Mutationen kein MPE produzieren. Zu diesem Zweck zeigten Zellen des Lewis-Lungenkarzinoms (LLC), des Kolon-Adenokarzinoms (MC38) und des malignen Pleuramesothelioms (AE17), die …
-
KRAS MUTATIONS IN NORMAL PANCREATIC TISSUE: INVESTIGATING THE ORIGINS AND IMPLICATIONS FOR TUMORIGENESIS
KRAS mutations are among the earliest and most frequent genetic alterations in pancreatic ductal adenocarcinoma (PDAC), occurring in over 90% of cases. To evaluate their presence in histologically normal pancreatic tissue, we used laser-capture microdissection (LCM) and droplet digital PCR (ddPCR) …
-
Lymphatic Malformations with Activating KRAS Mutations Impair Lymphatic Valve Development Through Matrix Metalloproteinases
… lesions that can be due to inherited or somatic mutations, and they lead to a defective lymphatic vasculature. Activating KRAS mutations have been identified recently in LM patients with lymphedema, chylous ascites, or life-threatening chylothorax. In a LM mouse model, KRAS mutations are …
-
Metabolic Reprogramming of Endothelial Cells with KRAS Mutations in the Pathobiology of Sporadic Brain Arteriovenous Malformations
… identified the presence of somatic activating KRAS mutations (p.G12D, p.G12V, p.Q61H) in endothelial cells (ECs) isolated from clinical bAVM tissue. Subsequent animal studies showed that EC-specific expression of mutant KRAS was sufficient to induce pathological vascular remodeling, resembling …
-
The role of KRAS mutations in the modulation of BAX and glycolytic metabolism using yeast as a model
O KRAS pertence à família de proteínas RAS GTPase, responsáveis pela regulação de várias vias de sinalização relacionadas com o controlo de importantes funções celulares, tais como a apoptose e o metabolismo. As mutações oncogénicas do KRAS são as mutações de ganho de função mais frequentes no …
-
Disclosing KRAS and Galectin-3 interaction in colorectal cancer cells and its impact on the tumor microenvironment
… and deadliest cancers worldwide. Oncogenic KRAS mutations are present in 30%-50% of the CRC cases, contributing to cancer cells self-sufficiency in proliferation, autophagy, and apoptosis evasion. KRAS mutations are crucial predictors of anti-epidermal growth factor receptor (EGFR) therapies …
-
Μελέτη του ρόλου των γονιδίων raf και ras στα κακοήθη νεοπλάσματα του παχέος εντέρου
… of MMR mutagenesis genes as well as additional mutations are steps which induce tumor genesis and contribute to malignant behaviour. RAS family genes (RAS, NRAS, HRAS), in normal cells, are involved in many cellular processes, controlling cell proliferation and differentiation. The protein …
-
Ανίχνευση μεταλλάξεων του EGFR και KRAS σε ασθενείς με μη-μικροκυτταρικό καρκίνο του πνεύμονα και διερεύνηση της αξίας τους ως προβλεπτικών παραγόντων ανταπόκρισης στη θεραπεία
… study was to investigate whether the EGFR and KRASmutation status are predictive factors for Greeks patients with NSCLC. Initially, wecalculated the rate and the pattern of EGFR and KRAS mutations in 639 patients withNSCLC and then we correlated the mutations status with …
-
Induction of Synthetic Lethality In Mutant Kras Cells For Non-Small Cell Lung Cancers Chemoprevention and Therapy
… and treatment approaches are sorely needed. Mutations and activation of KRAS occur frequently in tobacco users and the early stage of development of non-small cell lung cancers (NSCLC). So they are thought to be the primary driver for lung carcinogenesis. My work showed that KRAS mutations …
-
Μελέτη βιοδεικτών στο μη μικροκυτταρικό καρκίνο του πνεύμονα
… TPS was 1-49% and absent when TPS was <1%. EGFR mutations were detected by COBAS, while KRAS and BRAF by Pyrosequencing. ROS1 and ALK rearrangements were estimated by immunohistochemistry with positive cases being confirmed by CISH and FISH respectively. Finally, ERCC1 and RRM1 expression was …
-
Impact of mutated KRAS signalling on autophagy regulation in colorectal carcinoma
… most abundant causes of cancer related deaths. KRAS mutations ( KRASG13D, KRASG12D and KRASG12V) are frequent events in CRC, detected in about 30% to 50% of the clinical cases, and seem to play an important role in colon carcinogenesis. It is known that KRAS mutations are predictive biomarkers …
-
Μοριακή και ανοστοϊστοχημική διερεύνηση της μικροδορυφορικής αστάθειας (MSI) σε καρκινώματα παχέος εντέρου
… sequencing were applied to identify KRAS, BRAF, NRAS mutations and Microsatellite instability (MSI) status. Immunohistochemistry was used to characterize the associated Mismatch Repair Protein loss. Statistical calculations were performed using the statistical package SPSS v21.0. …
-
Μοριακοί δείκτες (προβλεπτικοί, προγνωστικοί παράγοντες) καρκίνου του στομάχου
… 91 patients. EBV-positive tumors and tumors with mutations had higher intratumoral CD8 tumor-infiltrating lymphocyte density (p=0.009 and p=0.017, respectively). PIK3CA mutations were correlated with VEGFA overexpression (p=0.042), while KRAS mutations and HER2 expression were mutually exclusive …
-
Mutation-specific and common phosphotyrosine signatures of KRAS G12D and G13D alleles
KRAS is one of the most frequently mutated genes across all cancer subtypes. Two of the most frequent oncogenic KRAS mutations observed in patients result in glycine to aspartic acid substitution at either codon 12 (G12D) or 13 (G13D). Although the biochemical differences between these two …
-
Trans-renal tumor DNA as a non-invasive liquid biopsy for KRAS mutation detection in pancreatic cancer
… liquid biopsy for detecting oncogenic KRAS hotspot mutations (G12/G13), which occur in over 90% of PDAC cases. A pilot study of patients with PDAC and other gastrointestinal malignancies was enrolled through the BC Cancer Agency in Vancouver. Paired urine and plasma samples were …
Page 1 of 6